| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 851.24B | 924.48B | 963.30B | 1.01T | 936.31B |
| Gross Profit | 90.97B | 94.42B | 88.61B | 89.56B | 83.59B |
| EBITDA | 43.41B | 50.52B | 46.03B | 45.81B | 44.02B |
| Net Income | 16.06B | 17.10B | 13.89B | 13.83B | 13.19B |
Balance Sheet | |||||
| Total Assets | 452.69B | 442.15B | 444.30B | 433.02B | 447.02B |
| Cash, Cash Equivalents and Short-Term Investments | 21.92B | 13.93B | 30.10B | 32.01B | 38.15B |
| Total Debt | 56.98B | 56.65B | 58.94B | 71.81B | 90.56B |
| Total Liabilities | 242.16B | 239.40B | 252.09B | 252.70B | 275.82B |
| Stockholders Equity | 181.77B | 172.28B | 162.54B | 152.96B | 144.30B |
Cash Flow | |||||
| Free Cash Flow | 31.58B | 19.53B | 24.98B | 22.61B | 28.96B |
| Operating Cash Flow | 45.07B | 31.71B | 34.54B | 34.80B | 39.95B |
| Investing Cash Flow | -15.62B | -28.33B | -6.60B | -3.19B | -19.11B |
| Financing Cash Flow | -21.49B | -19.43B | -29.92B | -37.75B | -17.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥23.03B | 17.63 | ― | 4.50% | 4.36% | 80.89% | |
69 Neutral | ¥222.94B | 11.38 | ― | 3.45% | -7.92% | -6.17% | |
69 Neutral | ¥84.22B | 19.05 | ― | 1.37% | -5.79% | 40.68% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
64 Neutral | ¥1.68T | 10.98 | 2.23% | 3.07% | -11.80% | 87.51% | |
62 Neutral | ¥3.55T | 14.66 | -0.15% | 2.74% | -4.52% | 19.27% | |
62 Neutral | ¥103.52B | 14.53 | ― | 2.57% | -0.05% | -10.24% |